CAT# | CPM-1-0493 |
Sequence | GAVQNEVTL |
Size | 50 Test, 100 Test | Antigen | Virus | Epitope Origin | HCV NS3 1629-1637 | MHC Restriction | H-2Db | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0129 | H-2Kd Influenza NP tetramer-TYQRTRALV-PE labeled | Inquiry | ||
CPM-1-0696 | HLA-A_02_01 Cyclin D1 tetramer-YLNDRVLRV-PE labeled | Inquiry | ||
CPM-1-0214 | H-2Kb Influenza PB1 tetramer-SSYRRPVGI-PE labeled | Inquiry | ||
CPM-1-0575 | HLA-A_02_01 HBV pol tetramer-FLLSLGIHL-APC labeled | Inquiry | ||
CPM-1-0285 | HLA-A_02_01 MAGE-A10 tetramer-GLYDGMEHL-APC labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Figure 1. The structural formula of ornipressinOrnipressin is a synthetic analogue of vasopressin, which is repl ...
Dalbavancin, marketed under the brand name of Dalvance, is a new semi-synthetic glycopeptide antibiotic for anti ...
Introduce of lipopeptide Lipopeptide (peptidolipid), also known as acylpeptide, is composed of hydrophilic peptide bond and l ...
Eptifibatide acetate is a white or white-off powder, soluble in water and freely soluble in 1% acetic in water, ...
An overview of Palmitoyl pentapeptide-4 The potential of topical peptides to improve aging skin has been widely discussed in ...